An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases.
Saved in:
| Title: | An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases. |
|---|---|
| Authors: | Liu P; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Pan Z; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Gu C; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Cao X; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Liu X; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Zhang J; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Xiao Z; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Wang X; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Guo H; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Ju D; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China., Deng SJ; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China. |
| Source: | Frontiers in immunology [Front Immunol] 2020 Nov 27; Vol. 11, pp. 596908. Date of Electronic Publication: 2020 Nov 27 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33329588 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Liu+P%22">Liu P</searchLink>; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Pan+Z%22">Pan Z</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Gu+C%22">Gu C</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Cao+X%22">Cao X</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Liu+X%22">Liu X</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Xiao+Z%22">Xiao Z</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Guo+H%22">Guo H</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Ju+D%22">Ju D</searchLink>; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Deng+SJ%22">Deng SJ</searchLink>; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2020 Nov 27; Vol. 11, pp. 596908. <i>Date of Electronic Publication: </i>2020 Nov 27 (<i>Print Publication: </i>2020). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33329588 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2020.596908 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 596908 Titles: – TitleFull: An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Liu P – PersonEntity: Name: NameFull: Pan Z – PersonEntity: Name: NameFull: Gu C – PersonEntity: Name: NameFull: Cao X – PersonEntity: Name: NameFull: Liu X – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Xiao Z – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Guo H – PersonEntity: Name: NameFull: Ju D – PersonEntity: Name: NameFull: Deng SJ IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 11 Text: 2020 Nov 27 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 11 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |